CureVac N.V (CVAC) Non-Current Deffered Revenue: 2019-2025
Historic Non-Current Deffered Revenue for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $196,961.
- CureVac N.V's Non-Current Deffered Revenue fell 99.62% to $196,961 in Q2 2025 from the same period last year, while for Jun 2025 it was $196,961, marking a year-over-year decrease of 99.62%. This contributed to the annual value of $51.8 million for FY2023, which is 30.08% down from last year.
- As of Q2 2025, CureVac N.V's Non-Current Deffered Revenue stood at $196,961, which was down 92.47% from $2.6 million recorded in Q3 2024.
- Over the past 5 years, CureVac N.V's Non-Current Deffered Revenue peaked at $789.4 million during Q2 2021, and registered a low of $196,961 during Q2 2025.
- Moreover, its 3-year median value for Non-Current Deffered Revenue was $52.0 million (2024), whereas its average is $44.7 million.
- In the last 5 years, CureVac N.V's Non-Current Deffered Revenue soared by 535,684.13% in 2021 and then tumbled by 99.62% in 2025.
- Quarterly analysis of 5 years shows CureVac N.V's Non-Current Deffered Revenue stood at $98.8 million in 2021, then decreased by 25.07% to $74.0 million in 2022, then plummeted by 30.08% to $51.8 million in 2023, then plummeted by 95.47% to $2.6 million in 2024, then slumped by 99.62% to $196,961 in 2025.
- Its Non-Current Deffered Revenue was $196,961 in Q2 2025, compared to $2.6 million in Q3 2024 and $52.2 million in Q2 2024.